These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15077037)

  • 1. Monotherapy with the novel human anti-CD154 monoclonal antibody ABI793 in rhesus monkey renal transplantation model.
    Kanmaz T; Fechner JJ; Torrealba J; Kim HT; Dong Y; Oberley TD; Schultz JM; Bloom DD; Katayama M; Dar W; Markovits J; Schuler W; Hu H; Hamawy MM; Knechtle SJ
    Transplantation; 2004 Mar; 77(6):914-20. PubMed ID: 15077037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of ABI793, a novel human anti-human CD154 monoclonal antibody, in cynomolgus monkey renal allotransplantation.
    Schuler W; Bigaud M; Brinkmann V; Di Padova F; Geisse S; Gram H; Hungerford V; Kleuser B; Kristofic C; Menninger K; Tees R; Wieczorek G; Wilt C; Wioland C; Zurini M
    Transplantation; 2004 Mar; 77(5):717-26. PubMed ID: 15021835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates.
    Elster EA; Xu H; Tadaki DK; Montgomery S; Burkly LC; Berning JD; Baumgartner RE; Cruzata F; Marx R; Harlan DM; Kirk AD
    Transplantation; 2001 Nov; 72(9):1473-8. PubMed ID: 11707732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful conversion from conventional immunosuppression to anti-CD154 monoclonal antibody costimulatory molecule blockade in rhesus renal allograft recipients.
    Cho CS; Burkly LC; Fechner JH; Kirk AD; Oberley TD; Dong Y; Brunner KG; Peters D; Tenhoor CN; Nadeau K; Yagci G; Ishido N; Schultz JM; Tsuchida M; Hamawy MM; Knechtle SJ
    Transplantation; 2001 Aug; 72(4):587-97. PubMed ID: 11544416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-CD40 therapy extends renal allograft survival in rhesus macaques.
    Pearson TC; Trambley J; Odom K; Anderson DC; Cowan S; Bray R; Lin A; Hollenbaugh D; Aruffo A; Siadak AW; Strobert E; Hennigar R; Larsen CP
    Transplantation; 2002 Oct; 74(7):933-40. PubMed ID: 12394833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of CD40-CD154 at the time of donor-specific blood transfusion does not lead to prolonged kidney allograft survival in nonhuman primates.
    Ringers J; Haanstra KG; Kroczek RA; Kliem K; Kuhn EM; Wubben J; Ossevoort MA; Volk HD; Jonker M
    Transplantation; 2002 Mar; 73(6):862-6. PubMed ID: 11923684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination induction therapy with monoclonal antibodies specific for CD80, CD86, and CD154 in nonhuman primate renal transplantation.
    Montgomery SP; Xu H; Tadaki DK; Celniker A; Burkly LC; Berning JD; Cruzata F; Elster EA; Gray G; Kampen RL; Swanson SJ; Harlan DM; Kirk AD
    Transplantation; 2002 Nov; 74(10):1365-9. PubMed ID: 12451232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of CD154 at the time of donor-specific blood transfusion does not improve kidney graft survival in rhesus monkeys.
    Ringers J; Ossevoort M; Haanstra K; Kroczek R; Volk D; Jonker M
    Transplant Proc; 2001; 33(1-2):524. PubMed ID: 11266938
    [No Abstract]   [Full Text] [Related]  

  • 9. IDEC-131 (anti-CD154), sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates.
    Preston EH; Xu H; Dhanireddy KK; Pearl JP; Leopardi FV; Starost MF; Hale DA; Kirk AD
    Am J Transplant; 2005 May; 5(5):1032-41. PubMed ID: 15816883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotoxin-treated rhesus monkeys: a model for renal allograft chronic rejection.
    Torrealba JR; Fernandez LA; Kanmaz T; Oberley TD; Schultz JM; Brunner KG; Peters D; Fechner JH; Dong Y; Hu H; Hamawy MM; Knechtle SJ
    Transplantation; 2003 Aug; 76(3):524-30. PubMed ID: 12923438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies investigating pretransplant donor-specific blood transfusion, rapamycin, and the CD154-specific antibody IDEC-131 in a nonhuman primate model of skin allotransplantation.
    Xu H; Montgomery SP; Preston EH; Tadaki DK; Hale DA; Harlan DM; Kirk AD
    J Immunol; 2003 Mar; 170(5):2776-82. PubMed ID: 12594309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates.
    Kirk AD; Harlan DM; Armstrong NN; Davis TA; Dong Y; Gray GS; Hong X; Thomas D; Fechner JH; Knechtle SJ
    Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8789-94. PubMed ID: 9238056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of humanized monoclonal antibody to rhesus CD11a in rhesus monkey cardiac allograft recipients.
    Poston RS; Robbins RC; Chan B; Simms P; Presta L; Jardieu P; Morris RE
    Transplantation; 2000 May; 69(10):2005-13. PubMed ID: 10852588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.
    Yuan X; Dong VM; Coito AJ; Waaga AM; Salama AD; Benjamin CD; Sayegh MH; Chandraker A
    Transplantation; 2002 Jun; 73(11):1736-42. PubMed ID: 12084995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of renal allograft rejection in primates by blocking the B7/CD28 pathway.
    Ossevoort MA; Ringers J; Kuhn EM; Boon L; Lorré K; van den Hout Y; Bruijn JA; de Boer M; Jonker M; de Waele P
    Transplantation; 1999 Oct; 68(7):1010-8. PubMed ID: 10532543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel, blocking, Fc-silent anti-CD40 monoclonal antibody prolongs nonhuman primate renal allograft survival in the absence of B cell depletion.
    Cordoba F; Wieczorek G; Audet M; Roth L; Schneider MA; Kunkler A; Stuber N; Erard M; Ceci M; Baumgartner R; Apolloni R; Cattini A; Robert G; Ristig D; Munz J; Haeberli L; Grau R; Sickert D; Heusser C; Espie P; Bruns C; Patel D; Rush JS
    Am J Transplant; 2015 Nov; 15(11):2825-36. PubMed ID: 26139432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection.
    Ardjomand N; McAlister JC; Rogers NJ; Tan PH; George AJ; Larkin DF
    Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3899-905. PubMed ID: 12939307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft survival in a rhesus renal transplant model after immunotoxin-mediated T-cell depletion is enhanced by mycophenolate and steroids.
    Fechner JH; Dong Y; Hong X; Brunner KG; Tsuchida M; Neville D; Scharff J; Lee F; Oberley TD; Peters D; Schultz JM; Manthei ER; Hamawy MM; Knechtle SJ
    Transplantation; 2001 Aug; 72(4):581-7. PubMed ID: 11544415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates.
    Kirk AD; Burkly LC; Batty DS; Baumgartner RE; Berning JD; Buchanan K; Fechner JH; Germond RL; Kampen RL; Patterson NB; Swanson SJ; Tadaki DK; TenHoor CN; White L; Knechtle SJ; Harlan DM
    Nat Med; 1999 Jun; 5(6):686-93. PubMed ID: 10371508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ASKP1240 combined with tacrolimus or mycophenolate mofetil on renal allograft survival in Cynomolgus monkeys.
    Song L; Ma A; Dun H; Hu Y; Zeng L; Bai J; Zhang G; Kinugasa F; Sudo Y; Miyao Y; Okimura K; Miura T; Daloze P; Chen H
    Transplantation; 2014 Aug; 98(3):267-76. PubMed ID: 24992357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.